Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alisporivir Follow-up in Non-SVR Patients
NCT02465203Phase 3Terminated
- Sponsor
- Novartis
- Start
- Sep 2012
- Primary completion
- Jan 2014
- Modality
- Small Molecules
- Countries
- 16
01
Overview
A Phase 3 trial of alisporivir in hepatitis C (HCV), sponsored by Novartis. Started Sep 2012; status: terminated.
02
Drugs
alisporivir
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT02465203.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02465203.